Adeboye H Adewoye
Overview
Explore the profile of Adeboye H Adewoye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
317
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Soumerai J, Ni A, Xing G, Huang J, Furman R, Jones J, et al.
Leuk Lymphoma
. 2018 Nov;
60(6):1438-1446.
PMID: 30407886
The CLL-IPI is a risk-weighted prognostic model for previously untreated patients with chronic lymphocytic leukemia (CLL), but has not been evaluated in patients with relapsed CLL or on novel therapies....
2.
Zelenetz A, Barrientos J, Brown J, Coiffier B, Delgado J, Egyed M, et al.
Lancet Oncol
. 2017 Feb;
18(3):297-311.
PMID: 28139405
Background: Bendamustine plus rituximab is a standard of care for the management of patients with relapsed or refractory chronic lymphocytic leukaemia. New therapies are needed to improve clinically relevant outcomes...
3.
De Boer R, Kotasek D, White S, Koczwara B, Mainwaring P, Chan A, et al.
Breast Cancer Res Treat
. 2012 Aug;
135(1):241-52.
PMID: 22872523
The purpose of this study was to investigate the safety, tolerability, and pharmacokinetics of motesanib when combined with docetaxel or paclitaxel in patients with metastatic breast cancer. In this open-label,...
4.
Kotasek D, Tebbutt N, Desai J, Welch S, Siu L, McCoy S, et al.
BMC Cancer
. 2011 Jul;
11:313.
PMID: 21791058
Background: This phase 1b study assessed the maximum tolerated dose (MTD), safety, and pharmacokinetics of motesanib (a small-molecule antagonist of VEGF receptors 1, 2, and 3; platelet-derived growth factor receptor;...
5.
Adewoye A, Chen T, Ma Q, McMahon L, Mathieu J, Malabanan A, et al.
Am J Hematol
. 2007 Oct;
83(4):271-4.
PMID: 17924548
Bone disease with osteoporosis and osteomalacia are common in sickle cell disease (SCD). Some patients have vitamin D deficiency and low bone mineral density (BMD). The role of vitamin D...
6.
Sebastiani P, Nolan V, Baldwin C, Abad-Grau M, Wang L, Adewoye A, et al.
Blood
. 2007 Jun;
110(7):2727-35.
PMID: 17600133
Modeling the complexity of sickle cell disease pathophysiology and severity is difficult. Using data from 3380 patients accounting for all common genotypes of sickle cell disease, Bayesian network modeling of...
7.
Adewoye A, Nolan V, McMahon L, Ma Q, Steinberg M
Haematologica
. 2007 Jun;
92(6):854-5.
PMID: 17550862
Severe acute pain is common in sickle cell disease (SCD). Increasingly overburdened emergency departments are not the most appropriate setting in which to manage pain that requires close monitoring and...
8.
Luo H, Adewoye A, Pilichowska M, Li M, Basran R, Steinberg M, et al.
Hemoglobin
. 2007 May;
31(2):135-9.
PMID: 17486494
alpha-Thalassemia (thal) is common all over the world. Most of the mutations encountered are of the deletional type. We now report two frameshift alpha-thal mutations: a novel alpha1-globin gene deletion...
9.
Masiello D, Heeney M, Adewoye A, Eung S, Luo H, Steinberg M, et al.
Am J Hematol
. 2007 Feb;
82(7):643-9.
PMID: 17278112
An infant with Hb SE disease is reported. He was clinically well. Review of the literature shows that patients aged 18 and younger are usually well. On the other hand,...
10.
Adewoye A, Ramsey J, McMahon L, Sakai O, Steinberg M
Am J Hematol
. 2006 Aug;
81(11):888-9.
PMID: 16929543
Sickle cell disease (SCD) may have ocular complications. We present the a case of a patient with SCD, with an acute painful episode involving the limbs and periorbital region, who...